Shanghai Jemincare Pharmaceutical

Jemincare is a leading Chinese pharmaceutical group that has evolved from a traditional medicine manufacturer into a modern, innovation-driven biopharmaceutical company. Headquartered in Nanchang with a major R&D center in Shanghai, the company focuses on developing high-quality therapeutics across oncology, nephrology, cardiovascular, and infectious diseases. Jemincare operates a robust pipeline featuring small molecules, monoclonal antibodies, and next-generation biologics, supported by state-of-the-art manufacturing facilities. The company has gained international recognition through high-profile out-licensing deals with global partners like Genentech and Orion Corporation. With a strong commercial presence in China and an expanding global R&D footprint, Jemincare is a key player in the modernization of the Chinese life sciences industry.